4.5 Article

Adolescent nondaily smokers: Favorable views of tobacco yet receptive to cessation

Journal

NICOTINE & TOBACCO RESEARCH
Volume 11, Issue 4, Pages 348-355

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ntr/ntp023

Keywords

-

Funding

  1. National Institute on Drug Abuse [K23DA020482]
  2. SC YTS

Ask authors/readers for more resources

Favorable views of cigarette use may be a potentiating factor that influences the progression of nicotine dependence among adolescents. Using data from the South Carolina Youth Tobacco Survey (2005-2007), a statewide two-stage cluster sample of students in Grades 6-12 (N = 7,385), we examined attitudes toward smoking and quit behaviors among adolescent smokers across a range of smoking frequencies. Compared with past-30-day nonsmokers, adolescents who smoked 1-2 days in the past month were more likely to believe that (a) smokers have more friends, (b) smoking looks cool, and (c) it is safe to smoke in the short term and then quit, but less likely to think that (d) tobacco is as addictive as other drugs and (e) smoking few cigarettes per day is harmful. Those who smoked 1-2 days in the past month were similar to more frequent smokers, including those who smoked daily. Similar findings were found for lifetime exposure to smoking. Among those who smoked 1-2 days in the previous month, motivation to quit (54%) and incidence of quit attempts (52% in past year) were slightly higher compared with heavier smokers. Even minimal levels of cigarette use are associated with favorable views of smoking, and adolescents with minimal levels of cigarette use resemble chronic smokers in several key ways. Adolescents at very early stages of cigarette use are at significant risk for chronic use. Tobacco control efforts should capitalize on motivation to quit with focused prevention strategies that arrest the progression from nondaily to daily smoking.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

E-cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study

Elias M. Klemperer, Janice Y. Bunn, Amanda M. Palmer, Tracy T. Smith, Benjamin A. Toll, K. Michael Cummings, Matthew J. Carpenter

Summary: This study found that quitting electronic nicotine delivery systems (ENDS) is not associated with quitting combustible tobacco products (CTPs) among current smokers, but there is a possible risk of relapse to smoking associated with quitting ENDS among former smokers.

ADDICTION (2023)

Letter Clinical Neurology

Smoking-Cessation Pharmacotherapy After Stroke and Transient Ischemic Attack: A Get With The Guidelines-Stroke Analysis

Neal S. Parikh, Cenai Zhang, Setareh Salehi Omran, Daniel Restifo, Matthew J. Carpenter, Lee Schwamm, Hooman Kamel

STROKE (2023)

Article Substance Abuse

Interest in quitting e-cigarette use by device type and smoking history in US adults

Amanda M. Palmer, Alana M. Rojewski, Matthew J. Carpenter, Elias M. Klemperer, Nathaniel L. Baker, Brandon T. Sanford, Benjamin A. Toll

Summary: This study examined the level of interest in e-cigarette cessation among users with different smoking histories and device types. The results showed that 68.21% of users planned to quit vaping, 17.27% attempted to quit in the past year, and 29.28% attempted to quit by cutting back in the past year. Users of cartridge and disposable devices had higher odds of interest in quitting, and individuals with no smoking history had higher odds of attempting to quit.

TOBACCO CONTROL (2023)

Article Oncology

Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort

Steve Power, Kathleen Bickel, Ronald C. Chen, Anne C. Chiang, Liz Garrett-Mayer, Issam Makhoul, Sarah S. Mougalian, Charles L. Shapiro, Robert Siegel, Cardinale Smith, Gabrielle B. Rocque, Mary May Kozlik, Stephanie T. S. Crist, Arif Kamal

Summary: Despite calls for early and widespread completion of advance directives (ADs), studies examining the link between AD completion and outcomes for cancer patients have conflicting findings. This study used the ASCO Quality Oncology Practice Initiative (QOPI) registry to compare end-of-life (EOL) quality measures and the impact of QOPI certification on patients with and without early AD completion. The study found that QOPI certification is associated with higher rates of early AD completion, but early AD completion is not associated with recognized EOL quality measures. Further research should focus on the timing, frequency, and content of AD discussions to demonstrate their impact on end-of-life care.

JCO ONCOLOGY PRACTICE (2023)

Article Oncology

Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment

Carmen Guerra, Alice Pressman, Patricia Hurley, Elizabeth Garrett-Mayer, Suanna S. Bruinooge, Alexandra Howson, Melinda Kaltenbaugh, Jen Hanley Williams, Leigh Boehmer, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Lola Fashoyin-Aje, Worta McCaskill-Stevens, Janette Merrill, Greg Nowakowski, Manali I. Patel, Amelie Ramirez, Victoria Zwicker, Randall A. Oyer, Lori J. Pierce

Summary: ASCO and the Association of Community Cancer Centers conducted a pilot study to improve racial and ethnic diversity in cancer clinical trials. The study found that most participating sites were satisfied with the assessment and identified opportunities for improvement and strategies to increase diversity. However, there were challenges in collecting specific data on race and ethnicity.

JCO ONCOLOGY PRACTICE (2023)

Article Psychology, Clinical

Nicotine replacement therapy for vaping cessation among mono and dual users: A mixed methods preliminary study

Amanda M. Palmer, Matthew J. Carpenter, Alana M. Rojewski, Kayla Haire, Nathaniel L. Baker, Benjamin A. Toll

Summary: This study evaluated the reasons for quitting e-cigarettes and assessed the feasibility and acceptability of nicotine replacement therapy (NRT) for e-cigarette cessation in treatment-seeking adults. Participants reported seeking treatment due to health concerns, dependence, stigma, and cost. The study found that participants who received NRT had a higher rate of abstinence from vaping compared to the control group.

ADDICTIVE BEHAVIORS (2023)

Article Psychology, Clinical

Daily adherence to nicotine replacement therapy in low-income smokers: The role of gender, negative mood, motivation, and self-efficacy

Jamie M. Gajos, Elizabeth S. Hawes, Sofia Mildrum Chana, Sylvie Mrug, Caitlin Wolford-Clevenger, Michael S. Businelle, Matthew J. Carpenter, Karen L. Cropsey

Summary: This study aimed to explore factors that affect nicotine replacement therapy (NRT) adherence among low-income smokers, particularly for women. The study found that negative mood, motivation, and self-efficacy were related to NRT adherence, and these associations varied by gender. Future research should focus on the impact of same-day negative mood, motivation, and self-efficacy on NRT adherence during smoking cessation interventions for low-income smokers.

ADDICTIVE BEHAVIORS (2023)

Article Public, Environmental & Occupational Health

E-Cigarette Screening in Primary Care

Brandon T. Sanford, Alana M. Rojewski, Amanda M. Palmer, Nathaniel L. Baker, Matthew J. Carpenter, Tracy T. Smith, Benjamin A. Toll

Summary: This study examined the screening rates for E-cigarette use during routine primary care visits and found that the rates were significantly lower than those for tobacco, alcohol, and illicit drugs. Additionally, it was found that patients who used combustible tobacco or illicit substances, as well as younger patients, were more likely to be screened for E-cigarette use.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2023)

Article Oncology

Genetic Associations with Smoking Relapse and Proportion of Follow-up in Smoking Relapse throughout Adulthood in Pre- and Postmenopausal Women

Stephanie K. Jones, Anthony J. Alberg, Kristin Wallace, Brett Froeliger, Matthew J. Carpenter, Bethany Wolf

Summary: This study investigated the genetic associations with smoking relapse among female smokers throughout adulthood. The findings revealed specific genetic variations that are associated with the likelihood and proportion of relapse, especially among postmenopausal women.

CANCER PREVENTION RESEARCH (2023)

Article Psychology, Biological

Development of Two Novel Treatments to Promote Smoking Cessation: Savor and Retrieval-Extinction Training Pilot Clinical Trial Findings

Amanda M. Palmer, Matthew J. Carpenter, Nathaniel L. Baker, Brett Froeliger, Madeline G. Foster, Eric L. Garland, Michael E. Saladin, Benjamin A. Toll

Summary: Despite progress, smoking still contributes significantly to disease burden, especially in rural communities. This study evaluated the feasibility and acceptability of two novel tobacco treatment interventions delivered remotely. Overall, both interventions showed promise in generating interest and engagement among smokers. A brief savoring intervention had effects on smoking, while a retrieval-extinction training did not.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2023)

Article Gerontology

The Impact of Older Age on Smoking Cessation Outcomes After Standard Advice to Quit

Margaret C. Fahey, Jennifer Dahne, Amy E. Wahlquist, Mathew J. Carpenter

Summary: This study examined the impact of age on the relationship between predictors of quitting smoking and successful cessation. The results showed that age had an interaction with motivation and nicotine dependence in predicting quit attempts. In terms of 6-month cessation, age had an interaction with motivation and a trend with dependence. Older adults had lower success rates compared to younger adults in those with high nicotine dependence, but had higher success rates among those unmotivated to quit.

JOURNAL OF APPLIED GERONTOLOGY (2023)

Article Medicine, Research & Experimental

The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial

Pam K. Mangat, Elizabeth Garrett-Mayer, Jacqueline K. Perez, Richard L. Schilsky

Summary: This article explores the conceptual framework of pragmatism in clinical trials using the American Society of Clinical Oncology's pragmatic, non-randomized, phase II, multi-center basket clinical trial, the Targeted Agent and Profiling Utilization Registry Study (NCT02693535), as an example. The study aims to evaluate the efficacy of FDA-approved drugs used outside their approved indications by matching them to pre-specified genomic targets in patients with advanced cancer. It also seeks to promote genomic testing and precision medicine education in community cancer centers. The implementation of the study demonstrates that a large, multi-center, precision medicine basket trial can generate clinically useful information with minimal burden to patients and clinical trial sites.

CLINICAL TRIALS (2023)

Article Substance Abuse

Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use

Michelle L. Sisson, Andres Azuero, Keith R. Chichester, Matthew J. Carpenter, Michael S. Businelle, Richard C. Shelton, Karen L. Cropsey

Summary: This study evaluated the effectiveness of online opioid overdose and naloxone administration education and the impact of naloxone possession. The results showed that overdose education in online video format was effective. The disparity in naloxone possession across groups indicates barriers to obtaining naloxone. Naloxone possession did not influence risky opioid use or treatment interest.

DRUG AND ALCOHOL DEPENDENCE (2023)

Article Oncology

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

Jennifer K. Litton, Meredith M. Regan, Lajos Pusztai, Hope S. Rugo, Sara M. Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K. Basho, Ana F. Best, Jean-Francois Boileau, Carsten Denkert, Jared C. Foster, Nadia Harbeck, Heather A. Jacene, Tari A. King, Ginny Mason, Ciara C. O'Sullivan, Tatiana M. Prowell, Andrea L. Richardson, Karla A. Sepulveda, Mary Lou Smith, Judy A. Tjoe, Gulisa Turashvili, Wendy A. Woodward, Lynn Pearson Butler, Elena I. Schwartz, Larissa A. Korde

Summary: The STEEP criteria, updated as STEEP 2.0 in 2021, provide standardized definitions for adjuvant breast cancer end points. A working group called NeoSTEEP was established to evaluate and align neoadjuvant breast cancer trial end points.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, Research & Experimental

And then I found $5: Optimizing recruitment efficiency in remote clinical trials

Margaret C. Fahey, Jennifer Dahne, Brian K. Chen, Tracy T. Smith, Amy E. Wahlquist, Mathew J. Carpenter

Summary: With the adoption of remote methodologies in clinical trials, there is a need to optimize the efficiency of remote enrollment. This study aims to assess sociodemographic factors among those consenting via mail versus technology-based procedures, determine if a small unconditional monetary reward increases subsequent enrollment, and evaluate the cost-effectiveness of the reward. Results show that older age, less education, lower income, and female sex predict enrolling via mail. Providing a $5 incentive increases the enrollment rate by 9% and the estimated cost per additional participant enrolled is $59.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

No Data Available